Joseph T. Baroldi - 15 Apr 2022 Form 4 Insider Report for IONIS PHARMACEUTICALS INC (IONS)

Role
EVP, Chief Business Officer
Signature
By: Patrick R. O'Neil, attorney-in-fact For: Joseph T. Baroldi
Issuer symbol
IONS
Transactions as of
15 Apr 2022
Net transactions value
$0
Form type
4
Filing time
19 Apr 2022, 20:22:41 UTC
Previous filing
02 Feb 2022
Next filing
05 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IONS Restricted Stock Unit Award $0 +43,350 $0.000000 43,350 15 Apr 2022 Common Stock 43,350 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant to reporting person of Restricted Stock Units under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan.
F2 Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
F3 Restricted Stock Units vest in four equal annual installments. Upon vesting, the Restricted Stock Units will be paid out in whole shares of Ionis common stock or cash as may be determined by Ionis.